Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 91693833 | 9169383 | 3 | F | 20120614 | 20160801 | 20130318 | 20160808 | EXP | NO-PFIZER INC-2012167929 | PFIZER | 68.00 | YR | F | Y | 0.00000 | 20160808 | PH | NO | NO |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 91693833 | 9169383 | 1 | PS | FLUOROURACIL. | FLUOROURACIL | 1 | Intravenous (not otherwise specified) | UNK | U | UNK | 202668 | ||||||||
| 91693833 | 9169383 | 2 | SS | OXALIPLATIN. | OXALIPLATIN | 1 | Intravenous (not otherwise specified) | UNK | U | OX211072 | 0 | ||||||||
| 91693833 | 9169383 | 3 | C | LEUCOVORIN. | LEUCOVORIN | 1 | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 91693833 | 9169383 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 91693833 | 9169383 | Blood pressure increased | |
| 91693833 | 9169383 | Dysarthria | |
| 91693833 | 9169383 | Dyspnoea | |
| 91693833 | 9169383 | Monoplegia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 91693833 | 9169383 | 1 | 20120614 | 20120614 | 0 | |
| 91693833 | 9169383 | 2 | 20120614 | 20120614 | 0 |